These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9137974)

  • 41. Expression of parathyroid hormone-related protein (PTHrP) in multiple myeloma.
    Kitazawa R; Kitazawa S; Kajimoto K; Sowa H; Sugimoto T; Matsui T; Chihara K; Maeda S
    Pathol Int; 2002 Jan; 52(1):63-8. PubMed ID: 11940209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant lymphoma masquerading as multiple myeloma.
    Chim CS; Ma SK; Leung CY
    Leuk Lymphoma; 1998 Feb; 28(5-6):607-11. PubMed ID: 9613993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone turnover following autologous transplantation in multiple myeloma.
    Clark RE; Fraser WD
    Leuk Lymphoma; 2002 Mar; 43(3):511-6. PubMed ID: 12002753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Relapse of multiple myeloma in extramedullary sites].
    Bairey O; Huminer D; Blickstein D; Sandbank Y; Shaklai M
    Harefuah; 1993 May; 124(9):539-41, 600. PubMed ID: 8340001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An unusual presentation of multiple myeloma in two cats.
    Weber NA; Tebeau CS
    J Am Anim Hosp Assoc; 1998; 34(6):477-83. PubMed ID: 9826282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Geranylgeranyl transferase type II inhibition prevents myeloma bone disease.
    Lawson MA; Coulton L; Ebetino FH; Vanderkerken K; Croucher PI
    Biochem Biophys Res Commun; 2008 Dec; 377(2):453-457. PubMed ID: 18929536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone.
    Knowling MA; Harwood AR; Bergsagel DE
    J Clin Oncol; 1983 Apr; 1(4):255-62. PubMed ID: 6668499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secretion of parathyroid hormone-related peptide in patients with multiple myeloma.
    Beaudreuil J; Cohen-Solal M; Doré MX; Vernejoul MC; Bardin T; Celton N; Giraudeaux V; Kuntz D
    Rev Rhum Engl Ed; 1996; 63(7-8):502-3. PubMed ID: 8896065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE; Siris ES; Jacobs TP
    Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Matrix metalloproteinases in multiple myeloma.
    Kelly T; Børset M; Abe E; Gaddy-Kurten D; Sanderson RD
    Leuk Lymphoma; 2000 Apr; 37(3-4):273-81. PubMed ID: 10752979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
    Miceli TS; Colson K; Faiman BM; Miller K; Tariman JD;
    Clin J Oncol Nurs; 2011 Aug; 15 Suppl(0):9-23. PubMed ID: 21816707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma.
    Xu L; Mohammad KS; Wu H; Crean C; Poteat B; Cheng Y; Cardoso AA; Machal C; Hanenberg H; Abonour R; Kacena MA; Chirgwin J; Suvannasankha A; Srour EF
    Cancer Res; 2016 Dec; 76(23):6901-6910. PubMed ID: 27634757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple myeloma in the marrow: pathogenesis and treatments.
    Fairfield H; Falank C; Avery L; Reagan MR
    Ann N Y Acad Sci; 2016 Jan; 1364(1):32-51. PubMed ID: 27002787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sclerotic lesions of bone in myeloma.
    Langley GR; Sabean HB; Sorger K
    Can Med Assoc J; 1966 Apr; 94(18):940-6. PubMed ID: 4952377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of multiple myeloma bone disease.
    Lentzsch S; Ehrlich LA; Roodman GD
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1035-49, viii. PubMed ID: 17996587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of markers of bone remodeling in multiple myeloma.
    Terpos E; Politou M; Rahemtulla A
    Blood Rev; 2005 May; 19(3):125-42. PubMed ID: 15748961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The role of the bone marrow microenvironment in the pathogenesis of multiple myeloma].
    Jurczyszyn A; Gdula-Argasińska J; Kosmaczewska A; Skotnicki AB
    Postepy Hig Med Dosw (Online); 2015 Apr; 69():521-33. PubMed ID: 25983291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amyloidoma of the clavicle.
    Rachbauer F; Kreczy A; Bodner G
    AJR Am J Roentgenol; 2003 Sep; 181(3):771-3. PubMed ID: 12933479
    [No Abstract]   [Full Text] [Related]  

  • 60. Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiography.
    Jakob C; Zavrski I; Heider U; Bollow M; Schulz CO; Fleissner C; Eucker J; Michael R; Hamm B; Possinger K; Sezer O
    Clin Cancer Res; 2003 Aug; 9(8):3047-51. PubMed ID: 12912955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.